{
    "2020-03-30": [
        [
            {
                "time": "2019-01-01",
                "original_text": "长春高新：2019年业绩大增，持续布局新赛道、新业务",
                "features": {
                    "keywords": [
                        "长春高新",
                        "业绩大增",
                        "新赛道",
                        "新业务"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-01",
                "original_text": "东阳光药：年报业绩靓丽，可威高速放量",
                "features": {
                    "keywords": [
                        "东阳光药",
                        "年报业绩",
                        "可威",
                        "高速放量"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-30",
                "original_text": "北上资金活跃股名单(3月30日)",
                "features": {
                    "keywords": [
                        "北上资金",
                        "活跃股名单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-31",
                "original_text": "司太立(603520.SH)2019年度净利润升81.83%至1.7亿元 拟10转4派3.5元",
                "features": {
                    "keywords": [
                        "司太立",
                        "净利润",
                        "增长",
                        "分红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-01",
                "original_text": "高盛刘劲津：A股底部为时不远 看好消费和5G板块",
                "features": {
                    "keywords": [
                        "高盛",
                        "A股",
                        "消费",
                        "5G"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-01-01",
                "original_text": "由量到质，创新再提速——2020年药监政策进展",
                "features": {
                    "keywords": [
                        "药监政策",
                        "创新",
                        "提速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-01",
                "original_text": "恒瑞市值破4000亿背后：创新与营销，究竟谁能为中国药企创造更多财富？",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "市值",
                        "创新",
                        "营销"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-30",
                "original_text": "北向资金逆势加仓医药股，抛售美的集团6亿元丨牛熊眼",
                "features": {
                    "keywords": [
                        "北向资金",
                        "医药股",
                        "美的集团"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "家电"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-01",
                "original_text": "定了！石药、恒瑞确认替补新基注射用紫杉醇集采供应市场",
                "features": {
                    "keywords": [
                        "石药",
                        "恒瑞",
                        "集采",
                        "紫杉醇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}